LianBio (NASDAQ: LIAN)
Some price data may be temporarily unavailable.
LianBio Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
LianBio Company Info
LianBio operates as a biopharmaceutical company, which engages in the development and commercialization of medicines for patients with unmet medical needs. It develops a portfolio of clinically validated product candidates for cardiovascular, oncology, ophthalmology, inflammatory disease, and respiratory indications. The company was founded by Konstantin Poukalov on July 17, 2019 and is headquartered in Princeton, NJ.
News & Analysis
Why LianBio Stock Is Shooting Through the Roof This Week
LianBio stock is seeing explosive gains, and it's one of this week's biggest winners.
Why LianBio Stock Is Skyrocketing Today
Investors are loving LianBio's new deal with Bristol Myers Squibb.
Valuation
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.